Our signature range, developed for people and animals, represents a breakthrough in the treatment of joint injury and degenerative diseases such as arthritis and osteoporosis. Bringing together patented, premium quality natural ingredients with the latest in molecular and cellular biology techniques, Interpath products work towards repairing and restoring damaged joints, and actively maintaining joint health.
The regenerative power of our exclusive active ingredient, Epiitalis, is a game-changer within the joint health industry, which, in the past, often limited its focus to pain relief and symptom management. As leaders in joint health, our dedication to evolving the science of our field is ongoing. We are deeply proud of the trust our customers place in us to guide them on the path of leading happier, healthier and more active lives.
Our products are currently available in Australia, New Zealand, the USA, Canada, Ireland, the United Kingdom, Netherlands, Portugal, Switzerland, China, Hong Kong, Japan, Singapore, South Africa and Taiwan with plans to launch in additional countries already in progress.
In 1998, Interpath’s story began with the devoted owners (Interpath founders Dan and Corina Bright) of an arthritic family pet, ‘Sasha’ the dog.
Dan and Corina, already well acquainted with the human health industry, were dissatisfied with veterinary treatment options available to ease Sasha’s pain. These were limited only to nonsteroidal anti-inflammatory drugs (NSAIDs). Known for a range of common side effects and health risks, NSAIDs were not a viable long-term option for Sasha, who was just 11 years old at the time. Seeing an opportunity to help not only Sasha, but also countless treasured pets suffering the debilitating effects of Osteoarthritis, Dan and Corina contracted scientific facilities to research joint function. Their hope was to uncover new natural actives and combinations that would provide outstanding results in the promotion of joint function and mobility in dogs and cats. After significant research and subsequent field trials, ‘SashasTM Blend’ – named, of course, after Sasha, became the first Australian-developed natural arthritis treatment to achieve veterinary registration with the Australian Pesticides and Veterinary Medicines Authority (APVMA) in 2001.
With a strong focus on research and development, Interpath plans to continue to lead innovation in their field ensuring they always provide the most advanced, effective, and safe joint health treatments for you and your pets.
After significant research and subsequent field trials, Sasha’s Blend – named, of course, after Sasha – became the first Australian-developed natural arthritis treatment to achieve veterinary registration with the Australian Pesticides and Veterinary Medicines Authority (APVMA) in 2001.
Thanks to Dan and Corina’s ingenuity, Sasha’s Blend gave Sasha her quality of life back. She ran and went swimming without pain, enjoying a wonderful life to the grand age of 18 – an incredible achievement and a wonderful testament to the effects of her namesake product.
Since then, Interpath has continued to expand, with an ongoing focus on research and development in the scientific field of joint health. We recently discovered our new, patented active ingredient, Epiitalis®️, after three years of ground-breaking trial work. A plant-based oil extract with a proven ability to repair and restore damaged joints, Epiitalis®️ is the cornerstone of our subsequent formula combinations. Today, Interpath’s product range stretches across Sasha’s Blend and 4CYTE™ joint health supplements for dogs and horses. In 2017, we launched OSTEO-RESTORE™ for humans, our advanced new formula for bone and joint health.